Metabolic Reprogramming in Glioblastoma Stem Cells Promotes Radiation Resistance Through a H3K18la/USP30/MBOAT2 Axis
Advanced Science · 2026-11 · 13 (61)
DOI: 10.1002/advs.77044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 12.08.2026. Verfasst von Zong Miao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China. Hauptthemen laut MEDLINE: Glioblastoma, Radiation Tolerance, Neoplastic Stem Cells, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Mesenchymal glioma stem cells (MES GSCs) are closely associated with glioblastoma radioresistance, yet the mechanisms linking MES‐state maintenance to ferroptosis resistance remain incompletely defined. Here, we show that MES GSCs exhibit enhanced glycolytic activity and lactate production, driven in part by MES‐associated transcriptional regulators that promote LDHA expression. LDHA‐derived lactate induces p300‐dependent H3K18 lactylation, which enhances USP30 transcription. USP30 subsequently stabilizes the lipid‐remodeling enzyme MBOAT2 by limiting its ubiquitination, leading to phosphatidylethanolamine remodeling toward ferroptosis‐resistant PE‐MUFA species. Disruption of this LDHA–H3K18la–USP30–MBOAT2 axis by LDHA inhibition, impaired H3K18 lactylation, USP30 inhibition, or MBOAT2 depletion increases lipid peroxidation, promotes ferroptosis, and sensitizes MES GSCs to irradiation. Lipid rescue experiments further identify PE‐MUFA remodeling as a functional mediator of MBOAT2‐dependent ferroptosis resistance. In intracranial xenografts, combined targeting of glycolysis and USP30 enhances radiotherapeutic efficacy without obvious treatment‐associated body weight loss under the tested conditions. These findings reveal a metabolic–epigenetic–lipid remodeling circuit that protects MES GSCs from ferroptosis and promotes radioresistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
- Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
- Neurovascular Center, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
ORCID-Profile: Juxiang Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Miao, Z., Gu, W., Ren, Y., Lu, C., Cai, W., Lu, J., Bao, Z., Zhou, Y., Li, R., Jin, K., Chen, C., Wang, H., Xu, L., & Chen, J. (2026). Metabolic Reprogramming in Glioblastoma Stem Cells Promotes Radiation Resistance Through a H3K18la/USP30/MBOAT2 Axis. Advanced Science, 13(61). https://doi.org/10.1002/advs.77044
Vancouver
Miao Z, Gu W, Ren Y, Lu C, Cai W, Lu J, et al. Metabolic Reprogramming in Glioblastoma Stem Cells Promotes Radiation Resistance Through a H3K18la/USP30/MBOAT2 Axis. Advanced Science. 2026;13(61). doi:10.1002/advs.77044
BibTeX
@article{Miao2026,
author = {Miao, Zong and Gu, Wei and Ren, Yimin and Lu, Chenfei and Cai, Wanzhi and Lu, Junnan and Bao, Zhongyuan and Zhou, Yanan and Li, Rong and Jin, Ke and Chen, Chao and Wang, Hongxiang and Xu, Lei and Chen, Juxiang},
title = {Metabolic Reprogramming in Glioblastoma Stem Cells Promotes Radiation Resistance Through a H3K18la/USP30/MBOAT2 Axis},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {61},
doi = {10.1002/advs.77044}
}
EUVIMED